Real-World Study Examines Genomic Profiling Challenges for Patients With Cancers of Unknown Primary
The researchers found that more than half of patients with CUP did not have sufficient tissue to undergo genomic profiling.
BostonGene, University of Miami Ink Precision Oncology Collaboration in High-Grade B-Cell Lymphoma
BostonGene will use its next-generation sequencing technologies to analyze tumor samples collected at Sylvester and help guide treatment selection accordingly.
Thermo Fisher Scientific, Pfizer Partner to Bring NGS-Based Cancer Tests to Underserved Markets
The collaboration will expand NGS-based tests for lung and breast cancers in more than 30 countries, where advanced genomic testing has been limited.
Tempus Gains FDA Premarket Approval for NGS Solid Tumor Profiling Test
The xT CDx is a 648-gene next-generation sequencing test that can help guide treatments for colorectal cancer patients with targeted therapies.
Merck, Moderna's Personalized Vaccine-Keytruda Combo Shines Across Biomarker Subgroups at AACR
Adding Moderna's vaccine to Merck's checkpoint inhibitor in the adjuvant treatment setting benefited melanoma patients, even across biomarker groups like TMB and PD-L1.